Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease

Michael T Rudd1, John A McCauley, Joseph J Romano

  • 1Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. michael_rudd@merck.com